MedTrace Logo

Adjuvant Therapy With Letrozole in Induction of Ovulation With Polycystic Ovarian Syndrome

NCT06405178 · Status: NOT_YET_RECRUITING · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 500

Last updated 2024-05-08

No results posted yet for this study

Summary

The aim of the study is to assess the efficacy of adjuvant therapy dapagliflozin, metformin as monotherapy and combination of both in comparison to control group in induction of ovulation with letrozole in women PCOS, focusing specifically on rates of ovulation and pregnancy.

Conditions

  • Polycystic Ovary

Interventions

DRUG

Metformin

Insulin Sensitizer

DRUG

Dapagliflozin

Sodium-Glucose Co-transporter-2

DRUG

Dapagliflozin/Metformin

Anti diabetic drug

DRUG

Letrozole

Aromataze inhibitor

Sponsors & Collaborators

  • Beni-Suef University

    lead OTHER

Principal Investigators

  • Sara A Beni-Suef University, MD · Beni-Suef University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-09-30
Primary Completion
2024-12-30
Completion
2024-12-30

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06405178 on ClinicalTrials.gov